Literature DB >> 7532

Studies on normal human bone marrow cultures in controlled environment thin-film culture systems.

S Gailani, W F McLimans, A Nussbaum, F Robinson, O Roholt.   

Abstract

Two thin film culture systems, the controlled environment steady state system (SS) and the rocker tube configuration of that system (RT), were used to identify some of the conditions that appear to maintain morphologic and functional characteristics of cells of human bone marrow explants in vitro. The systems configuration assured continual gassing, control and easy monitoring of the cultures. Cytocentrifuge preparations of media of specimens cultured in RT disclosed, though in decreasing numbers, various hematopoietic cells for periods exceeding one month. Hematopoietic cells shed from specimens cultured in the SS system were retained in the culture tubes; cells of the myelocytic series predominated for the first two weeks while an increasing number of monocytes and macrophages appeared in the media of of older cultures. Histologic examination of cultured explants disclosed preservation of the marrow architecture and the persistence of hematopoietic cells. Specimens cultured in RT tubes tended to be less cellular than similar cultures placed in dialysis bags or as cultured in the SS system. Immunoglobulins (Ig) were released into the culture media at a constant rate throughout the period of culture. Specimens that were cultured at a controlled pH of 7.4 released 2 to more than 4 times as much Ig as similar specimens maintained at a pH level of 7.1. There were no definitive differences in Ig levels in the cultures maintained at comparable pH levels and overlaid with various CO2 concentrations, i.e. 2%, 5%, 10% similarly, no differences in Ig levels were found in specimens cultured in media containing fetal bovine sera as opposed to horse sera.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 7532     DOI: 10.1007/BF02796314

Source DB:  PubMed          Journal:  In Vitro        ISSN: 0073-5655


  8 in total

1.  THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY.

Authors:  F C GREENWOOD; W M HUNTER; J S GLOVER
Journal:  Biochem J       Date:  1963-10       Impact factor: 3.857

2.  Diffusion-in-gel methods for immunological analysis.

Authors:  O OUCHTERLONY
Journal:  Prog Allergy       Date:  1958

3.  Erythropoietic progenitors capable of colony formation in culture: state of differentiation.

Authors:  C J Gregory; E A McCulloch; J E Till
Journal:  J Cell Physiol       Date:  1973-06       Impact factor: 6.384

4.  Specificities of prostaglandins B 1 , F 1 , and F 2 antigen-antibody reactions.

Authors:  L Levine; R M Gjtierrez Cernosek; H Van Vunakis
Journal:  J Biol Chem       Date:  1971-11-25       Impact factor: 5.157

5.  In vitro growth of normal and leukemic human bone marrow.

Authors:  C H Brown; P P Carbone
Journal:  J Natl Cancer Inst       Date:  1971-05       Impact factor: 13.506

6.  Human bone marrow colony growth in agar-gel.

Authors:  B L Pike; W A Robinson
Journal:  J Cell Physiol       Date:  1970-08       Impact factor: 6.384

7.  A controlled environment system for study of mammalian cell physiology.

Authors:  W F McLimans; D T Mount; S Bogitch; E J Crouse; G Harris; G E Moore
Journal:  Ann N Y Acad Sci       Date:  1966-10-07       Impact factor: 5.691

8.  Growth of human bone marrow in liquid culture.

Authors:  D W Golde; M J Cline
Journal:  Blood       Date:  1973-01       Impact factor: 22.113

  8 in total
  3 in total

1.  Effect of CO2 on short-term human lymphocyte culture in vitro.

Authors:  R S Verma; C Rubenstein; H Dosik
Journal:  In Vitro       Date:  1977-11

2.  Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors.

Authors:  J I Kurland; P W Kincade; M A Moore
Journal:  J Exp Med       Date:  1977-11-01       Impact factor: 14.307

3.  Prostaglandin E production by human blood monocytes and mouse peritoneal macrophages.

Authors:  J I Kurland; R Bockman
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.